Navigation Links
Human Genome Sciences Advances Oncology Portfolio
Date:4/16/2008

ombination with Velcade

(bortezomib) in advanced multiple myeloma, and expects to have data

available in the third quarter of 2008.

-- In December 2007, HGS initiated dosing of approximately 105 patients in

a randomized Phase 2 trial of HGS-ETR1 in combination with paclitaxel

and carboplatin as first-line therapy in advanced non-small cell lung

cancer, and expects to have data available in 2009.

-- Today, HGS announced that it plans by mid-2008 to initiate a randomized

Phase 2 trial of HGS-ETR1 in combination with Nexavar (sorafenib) in

hepatocellular cancer. The study in hepatocellular cancer will begin

with a safety lead-in to assure the safety of this combination therapy

in patients with hepatocellular cancer who are infected with hepatitis

C.

About the HGS IAP Inhibitor Program

In December 2007, the HGS oncology portfolio was further strengthened by a licensing and collaboration agreement between HGS and Aegera Therapeutics Inc. This agreement provides HGS with exclusive worldwide rights (excluding Japan) to develop and commercialize HGS1029 (formerly AEG40826) and other small- molecule inhibitors of IAP (inhibitor of apoptosis) proteins in oncology. Preclinical studies of HGS1029 in combination with the Company's TRAIL receptor antibodies demonstrated dramatic synergistic activity against a number of cancer types. HGS1029 has also shown significant anti-tumor activity alone and in combination with other agents in a broad range of cancers. HGS expects to initiate a Phase 1 clinical trial of HGS1029 by mid-2008 and plans to develop its TRAIL receptor antibodies and IAP inhibitors in combination with one another and in combination with other therapeutic agents.

About HGS-ETR1 and HGS-ETR2

HGS-ETR1 and HGS-ETR2 are agonistic human monoclonal antibodies that directly induce cancer-cell death by specifically binding to and activating th
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... date to $5 million. The orders are all odour control ... "We continue to see new orders coming in," said ... backlog has climbed to over $11 million." ... technology company that designs, manufactures and distributes a comprehensive line ...
(Date:9/23/2014)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... to announce that its wholly owned subsidiary, Portage ... to its team for further development of its ... cell permeable peptide platform technology derived from human ... eye. Ms. Holly Prentice ...
(Date:9/23/2014)... 2014   GenoSpace , a precision medicine software ... to enable the broad use of genomic data in ... been awarded Phase I of a Fast Track Small ... of Health (NIH) to enable enhanced data access and ... http://photos.prnewswire.com/prnh/20140922/147649 During the past decade, ...
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, ... the 280 nm wavelength range. This series joins Marktech’s ... 280nm to 405nm. These new devices are suitable for ... curing. Mark Campito, Marktech’s CEO states that “what makes ... is that we offer it in one of the ...
Breaking Biology Technology:Portage Announces New Consultants for its PPL-003 Development Programs 2Portage Announces New Consultants for its PPL-003 Development Programs 3Portage Announces New Consultants for its PPL-003 Development Programs 4GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Marktech Introduces its New Line of Deep UV Emitters 2
... , , , , , ... service for large insert vectors such as BACs, cosmids and fosmids. Agencourt , ... , rapid turnaround including: , ... strategies , Patented SPRI technology , ...
... ,Solutions Note ,, The time taken to ... for,researchers today. Whilst many manufacturers of,thermal cyclers focus ... article we highlight how Thermo's approach of focussing ... less than 1 hour. , Abstract ...
... , , , , RT-PCR amplification ... are specific for that mRNA sequence. The primer design should also , ... product derived from contaminating genomic DNA. There are two approaches , ... , , , , , ...
Cached Biology Technology:FULL LENGTH INSERT SEQUENCING 2Rapid PCR* Using Active Tube Temperature Control On Thermo's PCR Machines 2Rapid PCR* Using Active Tube Temperature Control On Thermo's PCR Machines 3
(Date:9/23/2014)... fall of an athlete,s moving body relies on an orchestrated ... angles and intersecting planes literally the geometry of ... But it,s more than just a footfall error at the ... the ACL or anterior cruciate ligament tear. In fact, size ... of the knee joint and volume of the ACL ...
(Date:9/23/2014)... Researchers have encountered variants or isoforms in microRNAs ... byproducts. A recent study, published in the journal ... isomiRs have abundances that depend on geographic subpopulations and ... given miRNA may not be the one typically listed ... microRNA isoforms are much more common than we had ...
(Date:9/23/2014)... Scientists often measure the effects of temperature on insects ... and abundance, but a Dartmouth study shows for the ... addition to temperature, ultimately limits how fast they grow. ... more about the overall environmental conditions that shape the ... lead author Lauren Culler , an Arctic postdoctoral ...
Breaking Biology News(10 mins):Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3Insects' fear limits boost from climate change, Dartmouth study shows 2
... BETHESDA, MD, USA, DECEMBER 1, 2011 The collaboration ... a more extensive and advanced facility for archiving, sharing, ... American Society for Cell Biology (ASCB) and the National ... University of California, San Diego (UCSD), have joined forces ...
... COLUMBIA, Mo. When a muscle is damaged, ... to "wake up" and contribute to repairing the muscle. ... satellite cells could help with the repair, and are ... tissue. This knowledge could ultimately help doctors more effectively ...
... A Michigan State University researcher is using a ... a portable wastewater treatment system that could improve ... is being spearheaded by Wei Liao, an MSU ... will generate energy and produce drinking water, thus ...
Cached Biology News:2 top biological imaging centers offer powerful free online tool to researchers and public 2Adult stem cells use special pathways to repair damaged muscle, MU researchers find 2Wastewater system generates energy, produces drinking water 2